SUL-151 as treatment for smoke-induced COPD

Sulfateq is happy to announce that a new scientific manuscript detailing the efficacy of SUL-151 to mitigate the development of Chronic Obstructive Pulmonary Disease (COPD), was recently published in the International Journal of Molecular Sciences. This manuscript...

SNN Valorisation grant for Sulfateq B.V.

We are proud to announce that Sulfateq B.V. received a Samenwerkingsverband Noord-Nederland (SNN) Valorisation grant for the development of SUL-138 as Acute Kidney Injury (AKI) prophylaxis. This grant helps us to continue the development that was already stimulated by...

New Paper about SUL-109

There is a new manuscript available which describes the positive effect of our SUL-109 compound which is commercially available as our ROKEPIE preservation solution. This article was written by Fatima Aerts from the Hacettepe University in Ankara (Turkey). You can...

Winterslaap voor de mens

In de zomer keihard doorgaan, en zodra het koud wordt, even de boel de boel laten. Rust. Voor velen aanlokkelijk, maar het lijkt nog toekomstmuziek. Professor Rob Henning (Rijksuniversiteit Groningen) scientific board van Sulfateq, denkt dat het in de toekomst...